FDA Approves DESIPRAMINE HYDROCHLORIDE — Amneal Pharmaceuticals NY LLC

# FDA Approves Desipramine Hydrochloride Generic Amneal Pharmaceuticals NY LLC has received FDA approval for its generic desipramine hydrochloride oral formulation, expanding treatment options for patients with depression and potentially reducing medication costs in the tricyclic antidepressant market. The approval of the ANDA application enables Amneal to compete in the established desipramine market, which could increase price competition and improve accessibility for patients requiring this therapeutic treatment.